ELI Lilly Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-08
Share capital
10,023,734.00 PLN
Registered address
Żwirki I Wigury 18A, 02-092 Warszawa, Poland
Electronic delivery address
AE:PL-33095-46018-AJDIU-34

Financials

Revenue history (in m)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 18 days late). All were audited by a statutory auditor.

  • 202530/06/2026
  • 202430/06/2025
  • 202328/06/2024
  • 202205/07/2023
  • 202102/08/2022
  • 202030/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 43.35mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 2.65mMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 38.99mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 16.78mMedianUSD 608.93kAverageUSD 11.85m

Industry

Trademarks

ELI Lilly Polska currently holds no active trademarks with the Polish Patent Office. 8 marks have expired or were not registered. The first mark was filed in 1996.

MarkNumberClassesStatusProtected until
Mark without a word element(figurative)Z.1575150, 5, 10, 41, 42Expired –
Mark without a word element(figurative)Z.1575140, 5, 10, 41, 42Expired –
V VITALPHARMAZ.1575160, 5, 10, 41, 42Expired –
VITALFARMAZ.1574700, 5, 10, 41, 42Expired –
VITALPHARMAZ.1574710, 5, 10, 41, 42Expired –
MarkProtected until
Mark without a word element(figurative)–
Mark without a word element(figurative)–
V VITALPHARMA–
VITALFARMA–
VITALPHARMA–

Authorized Representatives

Ahmed Abdelkhalek Abouelmaaty – President of the Management Board
Krzysztof Piotr Jasek – Vice President of the Management Board
Michał Łukasz Kłonowski – Attorney-in-fact (sole)
Tomasz Kubicki – Attorney-in-fact (sole)

Manner of representation

Each member of the management board, including the President or Vice-President of the Management Board, has the right to represent the company independently.

Ownership

OwnerSharesShare valueStake
Eli Lilly Nederland B.v.
24,681$2,706,776.3499.9676%
Others
8$877.360.0324%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-11-30.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Stada Pharmsp. z o.o.
Olympus Polskasp. z o.o.
ITPS.A.
AHP Logistykasp. z o.o.
Orkla CareS.A.
Idalia Ludwikowscysp. j.
APS Marcin WalasekS.K.A.
DiagnosisS.A.
Medicussp. z o.o.
Synkmedsp. z o.o.

Change history

DateEvent
2013-06-25Address change
2008-02-12Share capital reduction
2003-10-22Address change
2003-09-17Address change
2003-06-26Address change

FAQ

Last updated: 2026-10-06